How the Timing of Second Treatment with Nivolumab Relates to Survival in Advanced Kidney Cancer

Circadian rhythms influence immune function and drug response, highlighting the importance of ICI infusion timing in treatment.

• The study focuses on metastatic renal cell carcinoma (mRCC) and the use of immune checkpoint inhibitors (ICIs).
• Timing of ICI infusion may have a prognostic impact when administered after tyrosine kinase inhibitor (TKI) therapy.
• Interest in chronotherapy arises from the potential modulation of immune responses based on circadian rhythms.

Simplified